Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 28 ... for strong bones and a healthy immune system. Deficiency of vitamin D is associated with bone softening in adults, rickets in children and, more recently, with high blood pressure, ... sun exposure are safe, dermatologists point out that the risk of developing skin cancer from ultraviolet (UV) radiation far outweighs the benefit of stimulating vitamin D ...
2009 NOV 23 ... "Denosumab increased lumbar spine bone mineral density (BMD) versus placebo in a 2-year, randomized, placebo-controlled, phase ... phase 3 study of patients with hormone-receptor- positive, non-metastatic breast cancer and low bone mass who were receiving adjuvant aromatase inhibitor therapy. In subgroup ...
2009 NOV 23 ... (AED) and treated with HE3235. To investigate the effect of HE3235 on CaP tumor in the bone, castrated mice were injected intratibially with C4-2B CaP cells and treated with ... study results from the report, 'HE3235 inhibits growth of castration-resistant prostate cancer,' have been published. According to recent research from the United States, ...
2009 NOV 23 ... as paneth cells." "NOD2 has not been studied in experimental allogeneic bone marrow transplantation (allo-BMT). Using chimeric recipients with NOD2(-/-) ... For additional information, contact O. Penack, Mem Sloan Kettering Cancer Center, Dept. of Immunology, New York City, NY 10065, USA. The publisher of ...
2009 NOV 23 ... of thrombocytopenia in these patients, including chemotherapy-induced myelosuppression, bone marrow involvement with tumor, and DIC." James and colleagues published ... third-generation platinum compound that is commonly used for the treatment of colorectal cancer (CRC) both in the adjuvant and metastatic disease settings. Oxaliplatin-based ...
2009 NOV 23 ... and in vivo MM xenograft models, we show that plasmacytoid dendritic cells (pDCs) in the bone marrow (BM) microenvironment both mediate immune deficiency characteristic of MM and ... According to recent research published in the journal Cancer Cell, "Multiple myeloma (MM) remains incurable despite novel therapies, suggesting the ...
2009 NOV 23 ... concluded: "In the present paper, we will discuss the consequences of aging on murine bone marrow-derived DC function and their use in cancer immunotherapy." ...
2009 NOV 23 ... Sciences report. "When the three opioids were tested in the femur bone cancer model, all of them significantly reversed guarding behavior, whereas the effects on ...
2009 NOV 23 ... Fresh data on renal cell carcinoma are presented in the report 'A case of bone, lung, pleural and liver metastases from renal cell carcinoma which responded remarkably ... events (SREs) such as bone pain caused by bone metastasis from many kinds of cancer." "The patient in the present report had multiple bone metastases from ...
2009 NOV 23 ... and the (18)F-FDG-PET (PET) findings. The PET findings were negative in 4 metastatic bone lesions with a positive bone scan. The PET findings were also negative in 6 of 9 ... discuss in 'Multiple (18)F-FDG, PET-CT for postoperative monitoring of breast cancer patients' new findings in breast cancer. "Positron emission tomography (PET)-computed ...
2009 NOV 23 ... gondii components induce a potent antitumor response in a mouse model of fibrosarcoma. Bone-marrow derived DCs (BMDCs) were cultured in the presence of granulocyte-macrophage ... cells (DCs) as a cellular adjuvant is a promising approach to the immunotherapy of cancer. It has previously been demonstrated that DCs pulsed ex vivo with Toxoplasma gondii ...
2009 NOV 23 ... publish new data in the report 'The chemokine CCL2 increases prostate tumor growth and bone metastasis through macrophage and osteoclast recruitment.' "CC chemokine ligand 2 ... States report. "TAMs have been shown to promote tumor growth in several cancer types. Osteoclasts have also been known to play an important role in cancer bone ...
2009 NOV 23 ... gingiva of the upper incisor region, gingiva of the lower premolar region, and maxillary bone of the upper incisor region. Each patient underwent surgery as their initial therapy, ... The researchers concluded: "Management of LRPLN metastasis in oral cancer patients is a challenge for oral surgeons, but early detection by CT or MRI and surgery ...
2009 NOV 28 ... the earlier experiments to reprogram the stem cells to produce IDUA. They then performed bone marrow transplantation on the MPS I mice with the reprogrammed cells. The developing red ... syndrome, said Dao Pan, Ph.D., a researcher in the Division of Experimental Hematology/Cancer Biology at Cincinnati Children's and the study's principal author. It also is the ...
Subject: Cincinnati Children's Hospital Medical Center
2009 NOV 23 ... SWIFT allows the extension of MRI to high quality imaging of tissues such as bone and cartilage, where X-ray imaging methods are now commonly used. SWIFT is expected to ... used. SWIFT is expected to open new avenues in pre-clinical research areas such as cancer detection, drug labeling and tracking, and combination MR-PET applications. ...
2009 NOV 23 ... mandibular reconstruction with free tissue transfer and two by non-vascularized bone grafts. All procedures were successful. One patient developed deep vein thrombosis ... USA. Keywords: Australia, Dandenong, Ameloblastoma Therapy, Ameloblastoma, Cancer, Odontogenic Tumors, Oncology, Recurrence, Surgery, Therapy, Treatment. ...
2009 NOV 23 ... According to a study from Naples, Italy, "An altered expression of bone morphogenetic protein 4 (BMP4) has been found in malignant melanoma cells. We performed ... "This study evidences the relevance of using bioinformatics tools in searching for cancer-associated gene polymorphisms and suggests that the predicted functional SNP 6007 C/T ...
2009 NOV 23 ... vasomotor flushing, anemia, and fatigue. More recently, ADT has been shown to accelerate bone loss, increase fat mass, increase cholesterol and triglycerides, and decrease insulin ... Investigators publish new data in the report 'Prostate cancer survivorship: prevention and treatment of the adverse effects of androgen deprivation ...
2009 NOV 23 ... relapses at high rates following high-dose conventional cytotoxic therapy and autologous bone marrow cell (BMC) reconstitution. This study presents a series of transplant experiments ... the efficacy of allogeneic BMC transplantation," scientists writing in the journal Cancer Immunology Immunotherapy report. "Neuro-2a cells were found to express low ...
2009 NOV 23 ... quality of life," commented George Demetri, MD, Director of the Center for Sarcoma and Bone Oncology and the Ludwig Center at the Dana-Farber Cancer Institute and Harvard Medical ...
